This online webinar (14:00-15:00 CEST) will introduce and outline the objective of the BigData@Heart project: develop a data-driven translational research platform of unparalleled scale and phenotypical resolution, with the aim to improve patient outcomes and reduce societal burden of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS).

Logo BigData@Heart: Big Data for Better Hearts

The recently launched EU BigData@Heart project consists of patient networks, learned societies, SMEs, pharmaceutical companies and academia. It has three main objectives:

  • To deliver clinically relevant disease phenotypes underpinning research and innovation;
  • Gain more scalable insights from real world evidence, clinical- and pharmaco-epidemiology;
  • Gain advanced analytics insights driving drug development and personalised medicine.

The project will last for five year and was funded by the Innovative Medicines Initiative (IMI): a joint funding programme of the European Commission and the pharmaceutical industry.

More information about the project and the webinar